Mo. Code Regs. Ann. tit. 19, § 30-1.002
PURPOSE: The Department of Health and Senior Services has prepared a list of all drugs falling within the purview of controlled substances.
(1) Schedules of Controlled Substances.
(A) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Drug Enforcement Administration (DEA) Controlled Substances Code Number set forth opposite it.
or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
PP. 3-Methylfentanyl (N-(3- methyl-1-(2-phenylethyl)- 4-piperidyl)-N- phenylproanamide), its optical and geometric isomers, salts, and salts of isomers QQ. 3-Methylthiofentanyl (N- (3-methyl-1-(2- thienyl)ethyl-4-piperidinyl)- Nphenylpropanamide) RR. Morpheridine SS. MPPP (1-methyl-4-phenyl- 4-propionoxypiperidine) TT. MT–45 (1-cyclohexyl- 4-(1,2-diphenylethyl) piperazine) (9560) UU. Noracymethadol VV. Norlevorphanol WW. Normethadone XX. Norpipanone YY. N-(2-fluorophenyl)-2- methoxy-N- (1-phenethylpiperidin-4- yl)acetamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: ocfentanil) ZZ. ortho-Fluorofentanyl (N-(2- fluorophenyl)-N-(1- phenethylpiperidin-4-yl) propionamide); other name: 2-fluorofentanyl) AAA. para-Fluorobutyryl fentanyl (N-
yl)butyramide) BBB. Para-fluorofentanyl(N- (4-fluorophenyl)-N- (1-(2-phenethyl)-4- piperidinyl) propanamide CCC. PEPAP (1-(-2-phenethyl)- 4-phenyl-4- acetoxypiperidine) DDD. Phenadoxone EEE. Phenampromide FFF. Phenomorphan GGG. Phenoperidine HHH. Piritramide III. Proheptazine JJJ. Properidine KKK. Propiram LLL. Racemoramide MMM. N-(1-phenethylpiperidin- 4-yl)-N- phenyltetrahydrofuran-2- carboxamide, its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers (Other name: tetrahydrofuranyl fentanyl) AND SENIOR SERVICES
NNN. Thiofentany (N-phenyl-N- (1-(2-thienyl)ethyl-4- piperidinyl)- propanamide OOO. Tilidine PPP. Trimeperidine
ly excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Substances scheduled by the United States Drug Enforcement Administration as substances that share a pharmacological profile similar to fentanyl, morphine, and other synthetic opioids, unless specifically excepted or unless listed in another schedule. These substances are—
cyclohexyl]-N- methylbenzamide) 9547
specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation, which contains any quantity of the following hallucinogenic substances or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (For purposes of paragraph (1)(A)4. of this rule only, the term isomer includes the optical, position, and geometric isomers.):
Some trade or other names: etryptamine; Monase; alpha-ethyl-1H-indole-3-ethenamine; 3-(2-aminobutyl)indole; alpha-ET; and AET;
Some trade or other names: 4-bromo-2, 5- dimethoxy-a-methylphenethylamine; 4-bromo- 2, 5-DMA;
Some trade or other names: 2,5-dimethoxyamethylphenethylamine; 2,5-DMA;
Some trade or other names: DOET;
9335 (other name: 2C-T-7)
Some trade or other names: 4-methoxyamethylphenethylamine; paramethoxyamphetamine; PMA;
Some trade and other names: 4-methyl-2, 5- dimethoxy-a-methylphenethylamine; DOM; and STP;
Some trade and other names: 3-(b-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine;
Some trade and other names: N, N-Diethyltryptamine; DET;
Some trade or other names: DMT;
diisopropyltryptamine (other name: 5- MeODIPT)
Some trade and other names: 7-Ethyl- 6,6ß,7,8,9,10,12,13-octahydro-2-methoxy-6, 9-methano-5H-pyrido [1’,2’:1,2] azepino[5,4- b] indole; Tabernanthe iboga;
Some trade or other names: marijuana;
Some trade or other names: 3-Hexyl-1-
7518 hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran; Synhexyl;
Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds, or extracts;
contained in a plant of the genus Cannabis (cannabis 7370 plant), as well as synthetic
7405 equivalents of the substances contained in the U. 3,4-methylenedioxy-N- ethylamphetamine (also known as N-ethylalphamethyl-3,4 (methylenedioxy) phenethylamine, N-ethyl MDA, MDE, and MDEA) 7404 V. N-hydroxy-3,4- methylenedioxyamphetamine (also known as N-hydroxyalpha-methyl-3,4 (methylenedioxy) phenethylamine and N- hydroxy MDA) W. 3,4,5- trimethoxyamphetamine X. 5-MeO-DMT or 5-methoxy- N,N-dimethyltryptamine Y. Alpha-methyltryptamine Z. Bufotenine
AA. Diethyltryptamine
BB. Dimethyltryptamine
EE. Lysergic acid diethylamide 7315 FF. Marihuana
GG. Mescaline HH. Parahexyl
JJ. N-ethyl-3-piperidyl benzilate KK. N-methyl-3-piperidyl benzilate LL. Psilocybin MM. Psilocyn NN. Tetrahydrocannabinols naturally cannabis plant or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers, or both, with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
nol and their optical isomers;
cannabinol and their optical isomers;
cannabinol and its optical isomers; and
substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered; OO. Ethylamine analog of phencyclidine Some trade or other names: N-ethyl-1- phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl)-ethylamine, cyclohexamine, PCE; PP. Pyrrolidine analog of phencyclidine Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine PCPy, PHP; QQ. Thiophene analog of phencyclidine Some trade or other names: 1-(1-(2-thienyl)- cyclohexyl)-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP; RR. 1-(1-(2-thienyl)cyclohexyl) pyrrolidine Some other names: TCPy; SS. Salvia divinorum TT. Salvinorin A UU. 3-Fluoromethcathinone
CCC. N-(1-amino-3, 3-dimethyl-1- oxobutan-2-yl)-1-pentyl- 1H-indazole-3-carboxamide (ADB-PINACA)
7035 one) 7541 19 CSR 30-1
NNN. Pentedrone (Other names: α- methylaminovalerophenone; 2-(methylamino)-1- phenylpentan-1-one) 1246 OOO. Pentylone (Other names: bk- MBDP; 1-(1,3- benzodioxol- 5-yl)-2- (methylamino)pentan- 1-one) 7542 PPP. Naphyrone (Other names: naphthylpyrovalerone; 1- (naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan- 1-one) 1258 QQQ. alpha-pyrrolidinobutiophenone (Other names: α-PBP; 1-phenyl-2- (pyrrolidin- 1-yl)butan-1-one) 7546 RRR. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole- 3-carboxamide (Other names: AB- CHMINACA) 7031 SSS. N-(1-amino-3-methyl-1- oxobutan-2-yl)-1-pentyl- 1Hindazole-3-carboxamide (Other names: AB-PINACA) 7023 TTT. [1-(5-fluoropentyl)- 1H-indazol-3-yl](naphthalen- 1-yl)methanone (Other names: THJ-2201) 7024 UUU. N-(1-amino-3,3-dimethyl- 1-oxobutan-2-yl)-1- (cyclohexylmethyl)- 1H-indazole-3-carboxamide (Other names: MAB- CHMINACA; ADB-CHMINACA) 7032 VVV. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3,3- dimethylbutanoate (Other names: 5F–ADB; 5F–MDMB– PINACA) 7034 WWW. methyl 2-(1-(5- fluoropentyl)- 1H-indazole-3- carboxamido)-3- methylbutanoate (Other names: 5F– AMB) 7033 AND SENIOR SERVICES
Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
derived from 3-(1-naphthoyl)indole or 1Hindol- 3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Including, but not limited to:
derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent;
derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent, whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
(a) JWH-201, or 1-pentyl- 3-(4- methoxyphenylacetyl)indole
derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to:
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol), where side chain n=5, and homologues where side chain n-4, 6, or 7 7297, 7298
(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to:
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3- [ ( 2 R ) - 5 - p h e n y l p e n t a n - 2 - y l ] o x y - 5,6,6a,7,8,9,10,10a-octahydrophenanthridin- 1-yl] acetate; (VIII) HU-210, or (6aR,10aR)-9- (hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a , 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol;
Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)- 6,6-dimethyl-3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo[c]chromen-1- ol;
DMHP.
excepted or unless listed in another schedule, any material compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
other names GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutonic acid; sodium oxybate; sodium oxybutryrate 2010
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
Some trade or other names: aminoxaphen; 2- amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- phenyl-2-oxazolamine;
other names: BZP, 1- benzylpiperzaine) 7493
Some trade or other names: 2-(methylamino)- propiophenone; alpha-(methylamino) propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinine; AL-464; AL-422; AL-463 and URI 432;
(some other names: N,N-alpha-trimethylbenzeneethanamine; N,N-alphatrimethylphenethylamine)
subject to emergency scheduling under federal law shall include any material, compound, mixture, or preparation which contains any quantity of the following substances:
G. Fentanyl-related substances, their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers. 9850
means any substance not otherwise listed under another Administration Controlled Substance Code Number, and for which no exemption or approval is in effect under section 505 of the Federal Food, Drug, and Cosmetic Act 21 U.S.C. 355, that is structurally related to fentanyl by one (1) or more of the following modifications:
portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;
phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;
piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, or nitro groups;
ring with any aromatic monocycle whether or not further substituted in or on the aromatic 19 CSR 30-1
V. 4'-Methyl-alphapyrrolidinohexiophenone, its optical, positional, and geometric isomers, salts, and salts of isomers (Other names: MPHP; 4'-methylalpha-pyrrolidinohexanophenone; 1-(4- methylphenyl)-2-(pyrrolidin-1- yl)hexan-1-one) 7446
presently classified botanically as catha edulis, whether growing or not; the seeds thereof; any extract from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seed, or extracts. 7032
(B) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.
chemical synthesis. Unless specifically excepted or unless listed in another schedule, Schedule II shall include any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
compound, derivative, or preparation of opium or opiate, excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone and their respective salts, but including the following:
(V) Granulated opium 9640
preparation thereof which is chemically equivalent or identical with any of the substances referred to in subparagraph (1)(B)1.A. of this rule shall be included in Schedule II, except that these substances shall not include the isoquinoline alkaloids of opium;
compound, derivative, or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives, and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:
extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or
crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy)
or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan, and levopropoxyphene excepted:
Some other names: levo-alphaacetylmethadol, levomethadyl acetate, LAAM
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
5. Hallucinogenic substances:
Another name for nabilone: (±)trans-3-(1, 1- 9210 dimethylheptyl)-6, 6a,7,8,10,10a-hexahydro- 9220 1-hydroxy-6, 6-dimethyl-9H-dibenzo(b,d) 9240 pyran-9-one. 9250 B. Dronabinol tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the 9254 United States Food and Drug Administration.
ically excepted or unless listed in another
9802 schedule, any material, compound, mixture, 9230 or preparation which contains any quantity of the following substances:
9232 amphetamine and methamphetamine:
Some trade or other names: phenyl-2-
9233 propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;
9234 dine (PCP):
9739 C. Immediate precursor to fentanyl:
preparation which contains any quantity of the following alkyl nitrites:
1100 and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in 1205 this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. 1105 1. Stimulants. Unless specifically excepted or unless listed in another schedule, 1724 any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
preparations in dosage unit form containing
2125 any stimulant substances listed in Schedule II 2550 which compounds, mixtures, or preparations 2270 were listed on August 25, 1971, as excepted 7471 compounds under 21 CFR 308.32 and any 2315 other drug of the quantitive composition shown in that list for those drugs or which is 7379 the same except that it contains a lesser quantity of controlled substances [(-)-delta-9-trans
(7365)
precursor
(II) N-phenyl-N-(piperidin- 4-yl)propionamide (norfentanyl)
excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
preparation containing—
to
8501 or any salt thereof and one (1) or more other active medicinal ingredients which are not listed in any schedule;
taining—
or any salt of any of these drugs and approved
8603 by the Food and Drug Administration for marketing only as a suppository;
8333 quantity of a derivative of barbituric acid or any salt thereof
gamma hydroxybutyric acid, including its salts, isomers, and salts of isomer, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act;
or any salt thereof Some trade or other names for a tiletaminezolazepam combination product: Telazol. Some trade or other names for tiletamine: 2- (ethylamino)-2-(2-thienyl)-cyclohexanone. Some trade or other names for zolazepam: 4- ( 2 - f l u o ro p h e ny l ) - 6 - 8 - d i hyd ro - 1 , 3 , 8 - trimethylpyrazolo-(3,4-e) 7(1H)-one, flupyrazapon.
1405 4. Narcotics drugs. Unless specifically 19 CSR 30-1
A. Any compound, mixture, or
B. Any suppository dosage form con-
O. Tiletamine and zolazepam
(1,4)-diazepin- AND SENIOR SERVICES
excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:
grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium 9803
grams (1.8gm) of codeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9804
tenths grams (1.8gm) of dihydrocodeine per one hundred milliliters (100 mL) or not more than ninety milligrams (90 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9807
ligrams (300 mg) of ethylmorphine per one hundred milliliters (100 mL) or not more than fifteen milligrams (15 mg) per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9808
ligrams (500 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm) or not more than twenty-five milligrams (25 mg) per dosage unit, with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts 9809
mg) of morphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm), with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts 9810
preparation containing any of the following narcotic drugs or their salts, as set forth below:
excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts of isomers is possible within the specific chemical designation. DEA has assigned code 4000 for all anabolic steroids. Anabolic steroids. Any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that promotes muscle growth, except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for that administration. If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this paragraph. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters, and ethers:
droxy-5α-androst-1-ene)
droxy-5α-androst-1-ene)
droxy-androst-4-ene)
droxy-androst-5-ene)
1-en-3,17-dione)
3,17-dione)
3,17-dione)
17β-hydroxyandrost-4-en-3-one)
4-diene-3-one)
3,17-dione)
17β-hydroxyandrost-4-en-3-one)
yandrost-4-en-3-one)
(4-chloro-17β-hydroxy-17α-methyl-androst- 1, 4-dien-3-one)
methyl-5α-androst-2-en-17β-ol) (a.k.a. madol)
testosterone’) (17β-hydroxy-5α-androst-1-en- 3-one)
hydroxy-androstan-3-one)
methyl-5α-androstan-3-one)
hydroxyestr-4-ene)
methyl-11β,17β-dihydroxyandrost-4-en-3- one)
formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one)
hydroxyandrostano[2,3-c]-furazan)
one
dihydroxy-androst-4-en-3-one) AA. 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one) BB. Mestanolone (17α-methyl-17β- hydroxy-5α-androstan-3-one)
hydroxy-[5α]-androstan-3-one)
17β-hydroxyandrost-1,4-dien-3-one) EE. Methandriol (17α-methyl- 3β,17β-dihydroxyandrost-5-ene) FF. Methasterone (2α,17α-dimethyl- 5α-androstan-17β-ol-3-one) GG. Methenolone (1-methyl-17β- hydroxy-5α-androst-1-en-3-one) HH. 17α-methyl-3β,17β-dihydroxy- 5α-androstane
androstane JJ. 17α-methyl-3β,17β-dihydroxyandrost-4-ene KK. 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4- en-3-one)
17β-hydroxyestra-4,9(10)-dien-3-one)
17β-hydroxyestra-4,9,11-trien-3-one) NN. Methyltestosterone (17α-methyl- 17-hydroxyandrost-4-en-3-one) OO. Mibolerone (7α,17α-dimethyl- 17β-hydroxyestr-4-en-3-one) PP. 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst- 1-en-3-one) (a.k.a. 17-α-methyl-1-testosterone) QQ. Nandrolone (17β-hydroxyestr-4- ene-3-one) R R . 1 9 - n o r - 4 - a n d r o s t e n e d i o l (3β,17β-dihydroxyestr-4-ene) SS. 19-nor-4-andro stenediol (3α,17β-dihydroxyestr-4-ene) TT. 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) UU. 19-nor-5-androstenediol (3β,17β- dihydroxyestr-5-ene) V V. 1 9 - n o r - 5 - a n d r o s t e n e d i o l (3α,17β-dihydroxyestr-5-ene) WW. 19-nor-4-androstenedione (estr- 4-en-3,17-dione)
5-en-3,17-dione) YY. Norbolethone (13β,17α-diethyl- 17β-hydroxygon-4-en-3-one) ZZ. Norclostebol (4-chloro-17β- hydroxyestr-4-en-3-one) AAA. Norethandrolone (17α-ethyl- 17β-hydroxyestr-4-en-3-one) BBB. Normethandrolone (17α- methyl-17β-hydroxyestr-4-en-3-one)
hydroxy-2-oxa-[5α]-androstan-3-one)
4,17β-dihydroxyandrost-4-en-3-one) EEE. Oxymetholone (17α-methyl-2- hyd rox y m e t hy l e n e - 1 7 β - hyd rox y - [ 5 α ] - androstan-3-one) FFF. Prostanozol (17β-hydroxy-5α- androstano[3,2-c]pyrazole) GGG. Stanolone (Δ1-dihydrotestosterone (a.k.a. 1-testosterone)(17β-hydroxy- 5α-androst-1-en-3-one)) HHH. Stanozolol (17α-methyl-17β- hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole)
methyl-[5α]-androst-1-en-3-one) JJJ. Testolactone(13-hydroxy-3-oxo- 13,17-secoandrosta-1,4-dien-17-oic acid lactone) KKK. Testosterone(17β-hydroxyandrost-4-en-3-one);
diethyl-17β-hydroxygon-4,9, 11-trien-3-one)
4,9,11-trien-3-one) NNN. Any salt, ester, or isomer of a drug or substance described or listed in this subparagraph, if that salt, ester, or isomer promotes muscle growth except an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the secretary of Health and Human Services for that administration.
oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product 7369 (Some other names for dronabinol: (6aRtrans)- 6a,7,8,10a-tetrahydro-6.6.9- trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1- ol, or (-) -delta-9-(trans)-tetrahydrocannabinol.)
(D) Schedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it.
excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof:
mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five micrograms (25 mcg) of atropine sulfate per dosage unit 9167
4-dimethylamino-1,2-diphenyl-3-methyl-2- propionoxybutane) 9278
methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers, and salts of these isomers (including tramadol)
cotic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following limited quantities of narcotic drugs or salts thereof, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
milligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm); or
milligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm).
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Z. Fospropofol AA. Halazepam BB. Haloxazolam
pound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such
2731 salts, isomers, and salts of isomers is possi- 2882 ble:
2400 4. Lorcaserin. Any material, compound, 2748 mixture, or preparation which contains any 2749 quantity of the following substances, includ- 8192 ing its salts, isomers, and salts of isomers, 2460 whenever the existence of such salts, isomers, 2465 and salts of isomers is possible:
2751 5. Stimulants. Unless 2737 excepted or unless listed in another schedule, 2768 any material, compound, mixture, or prepa- 2752 ration which contains any quantity of the fol- 2753 lowing substances having a stimulant effect 2754 on the central nervous system, including its 2765 salts, isomers, and salts of isomers: 19 CSR 30-1
H. Pemoline (including organometallic complexes and chelates thereof) AND SENIOR SERVICES
excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:
mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including their salts, isomers, and salts of isomers:
mers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient.
(E) Schedule V shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this subsection.
ic active medicinal ingredients. Any compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as follows, which shall include one (1) or more nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal qualities other than those possessed by the narcotic drug alone:
ligrams (200 mg) of codeine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
ligrams (100 mg) of dihydrocodeine per one hundred milliliters (100 mL) or per one hun- 1640 dred grams (100 gm); 1750 C. Not more than one hundred mil- 1675 ligrams (100 mg) of ethylmorphine per one hundred milliliters (100 mL) or per one hundred grams (100 gm);
1650 milligrams (2.5 mg) of diphenoxylate and not less than twenty-five micrograms (25 mcg) of 1635 atropine sulfate per dosage unit;
ligrams (100 mg) of opium per one hundred milliliters (100 mL) or per one hundred grams (100 gm); and
9709 ligram (0.5 mg) of difenoxin (DEA Drug Code No. 9168) and not less than twenty-five 9720 micrograms (25 mcg) of atropine sulfate per dosage unit.
exempted or excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system including its salts, isomers, and salts of isomers:
9725 A. Pyrovalerone 1485
tion containing any detectable quantity of pseudoephedrine or its salts or optical isomers, or salts of optical isomers or any compound, mixture, or preparation containing any detectable quantity of ephedrine or its salts or optical isomers, or salts of optical isomers if the drug preparations are starchbased solid dose forms, if such preparations are sold over the counter without a prescription. The following drug preparations containing ephedrine and pseudoephedrine are not scheduled controlled substances:
prescription in order to be dispensed.
excluded or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts:
Bioline Laboratories Aphena Pharma Solutions—New York, LLC Goldline Laboratories Goldline Laboratories Hawthorne Products, Inc. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parke-Davis & Co. Parmed Pharmacy Rondex Labs Smith Kline Consumer Sterling Drug, Inc. Sterling Drug, Inc. Vicks Chemical Co. White Hall Labs
AUTHORITY: section 195.015, RSMo Supp. 2020, and section 195.195, RSMo 2016.* Material found in this rule previously filed as 19 CSR 30-1.010. Original rule filed April 14, 2000, effective Nov. 30, 2000. Amended: Filed Jan. 31, 2003, effective July 30, 2003. Amended: Filed Sept. 30, 2016, effective May 30, 2017. Emergency amendment filed Oct. 25, 2018, effective Nov. 4, 2018, expired May 2, 2019. Amended: Filed Oct. 25, 2018, effective April 30, 2019. Emergency amendment filed Oct. 30, 2020, effective Nov. 16, 2020, expired May 14, 2021. Amended: Filed Oct. 30, 2020, effective April 30, 2021. *Original authority: 195.015, RSMo 1971, amended 1989, 2014, 2020 and 195.195, RSMo 1957, amended 1971, 1989, 1993, 2014.